Specifically in this experiment, SB demonstrated the ability to decrease the blood concentration of tumor specific markers such as CEA, TNF-alpha, IL-6 and liver function markers (including ALT and AST) in the treated groups. This evidence concerns the gene CEACAM5 and neoplasm.